GROUP ONE TRADING, L.P. - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 150 filers reported holding OCULAR THERAPEUTIX INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.9%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$25,999
-87.6%
8,280
-79.2%
0.00%
-100.0%
Q1 2023$209,440
+238.9%
39,742
+80.7%
0.00%
Q4 2022$61,798
-60.4%
21,992
-41.6%
0.00%
Q3 2022$156,000
+225.0%
37,689
+214.9%
0.00%
Q2 2022$48,000
+860.0%
11,970
+1031.4%
0.00%
Q1 2022$5,000
-98.8%
1,058
-97.5%
0.00%
Q3 2021$425,000
-63.8%
42,495
-48.6%
0.00%
-100.0%
Q2 2021$1,173,000
+41.0%
82,727
+63.3%
0.00%0.0%
Q1 2021$832,000
-36.6%
50,675
-20.1%
0.00%
-50.0%
Q4 2020$1,313,000
+976.2%
63,431
+295.9%
0.00%
Q3 2020$122,000
+713.3%
16,023
+226.5%
0.00%
Q3 2019$15,000
-65.1%
4,907
-54.7%
0.00%
Q4 2018$43,000
-64.5%
10,827
-38.4%
0.00%
-100.0%
Q3 2018$121,000
+476.2%
17,572
+275.1%
0.00%
Q4 2017$21,000
-30.0%
4,684
-3.5%
0.00%
Q3 2017$30,000
-37.5%
4,854
-5.9%
0.00%
-100.0%
Q1 2017$48,000
+37.1%
5,160
+22.7%
0.00%
Q4 2016$35,000
-23.9%
4,205
-37.6%
0.00%
Q3 2016$46,000
+70.4%
6,742
+250.6%
0.00%
Q3 2015$27,0001,9230.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2021
NameSharesValueWeighting ↓
SUMMER ROAD LLC 5,618,861$116,310,000100.00%
Opaleye Management Inc. 6,510,000$134,758,00017.60%
DELTEC ASSET MANAGEMENT LLC 2,168,573$44,889,0006.87%
Versant Venture Management, LLC 1,465,384$30,333,0003.15%
GREAT POINT PARTNERS LLC 856,162$17,723,0002.88%
Affinity Asset Advisors, LLC 220,000$4,554,0002.41%
Altium Capital Management LP 303,174$6,276,0002.34%
Endurant Capital Management LP 290,465$6,013,0002.17%
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 50,396$1,043,0001.17%
Lisanti Capital Growth, LLC 366,040$7,577,0001.05%
View complete list of OCULAR THERAPEUTIX INC shareholders